Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pediatric Clinics of North America|May 28, 2018
von Willebrand Disease: Diagnostic Strategies and Treatment OptionsChristopher J Ng, Jorge Di PaolaTransfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 2, 2018
Current approaches to diagnostic testing in von Willebrand DiseaseEmily Southard Rao, Christopher J NgPlos One|March 21, 2025
Correction: Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cellsAllaura A Cox, Alice Liu, Christopher J NgPlos One|February 16, 2024
Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cellsAllaura A Cox, Alice Liu, Christopher J NgJournal of Thrombosis and Haemostasis : JTH|March 5, 2026
Recommendation to adopt the Type 1C VWD nomenclature into the classification of von Willebrand disease: Communication from the ISTH SSC Subcommittee on von Willebrand Factor (VWF)Christopher J Ng, Ross I Baker, Michelle Lavin, et al.Thrombosis Research|May 28, 2015
Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasisBrian R Branchford, Christopher J Ng, Keith B Neeves, et al.Thrombosis Research|August 18, 2016
Mutations in the D'D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWFTara C White-Adams, Christopher J Ng, Paula M Jacobi, et al.Blood|February 10, 2022
Single-cell transcriptional analysis of human endothelial colony-forming cells from patients with low VWF levelsChristopher J Ng, Alice Liu, Sujatha Venkataraman, et al.Research and Practice in Thrombosis and Haemostasis|August 11, 2021
Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single-center reportBeth Boulden Warren, Adrian Chan, Marilyn Manco-Johnson, et al.Pageof 2